EUCTR2008-004331-38-ITActive, not recruitingNot Applicable
Randomized study on the effectiveness, safety and acceptability 'of clobetasol propionate foam-cooled (OLUX) in comparison with cream aceponato methylprednisolone in the treatment of allergic contact dermatitis. - OLUX 01/08
MIPHARM0 sitesStarted: October 13, 2008Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •both sexes aged between 18 and 70 years, suffering from allergic contact dermatitis mild to moderate with involvement of body surface area not exceeding 20%, providing written informed consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •allergic contact dermatitis to corticosteroids, allergic dermatitis from skin contact with interest exceeding 20%, pregnant or breastfeeding, use of corticosteroids topical or systemic in the last 4 weeks preceding the recruitment, use of immunosuppressive drugs in the last 6 months prior to recruitment , Use throughout the period of the study of cosmetic preparations can, in the opinion of the investigator, to some extent influence the assessment of the patient and / or interfere on clinical response preparations in the trial
Investigators
Similar Trials
Not yet recruiting
Phase 3
A Study of AAV5-hRKp.RPGR for the Treatment ofJapanese Participants with X-linked Retinitis PigmentosaX-Linked Retinitis PigmentosaJPRN-jRCT2031230141umaguchi Hirotaka4
Active, not recruiting
Not Applicable
A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy From Alendronate to Denosumab (AMG 162) in Postmenopausal Women with Low Bone Mineral DensityPostmenopausal Osteoporosis/osteopeniaEUCTR2006-000849-19-EEAmgen Inc500
Active, not recruiting
Not Applicable
A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy From Alendronate to Denosumab (AMG 162) in Postmenopausal Women with Low Bone Mineral DensityEUCTR2006-000849-19-PTAmgen Inc500
Active, not recruiting
Not Applicable
A Randomized Study to Evaluate Safety and Efficacy of Transitioning Therapy from Alendronate to Denosumab AMG 162 in Postmenopausal Women with Low Bone Mineral Density - STANDEUCTR2006-000849-19-ITAMGEN S.P.A.500
Completed
Not Applicable
A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShunt® Glaucoma Drainage System to Standard Trabeculectomy In Subjects with Primary Open Angle Glaucomaintraocular pressurelowering the pressure in the eye10018307NL-OMON46024InnFocus, Inc.35